Drugs (Pharmaceuticals) – Page 42

Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients

The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system.

By Gina Kolata

Crispr (DNA) CRISPR Therapeutics Drugs (Pharmaceuticals) Food and Drug Administration Genetic Engineering Sickle Cell Anemia Therapy and Rehabilitation Vertex Pharmaceuticals Inc

F.D.A. Experts Will Vote on a Cure for Sickle Cell Disease

The treatment from the company Vertex would be the first medicine to use the gene editing tool CRISPR.

By Gina Kolata

Drugs (Pharmaceuticals) Eyes and Eyesight Food and Drug Administration Infections Regulation and Deregulation of Industry United States

Eyedrops From Major Brands May Cause Infection, F.D.A. Says

Target, CVS and Rite Aid are pulling products from shelves after federal investigators found unsanitary conditions and recommended a recall.

By Rebecca Carballo

Drugs (Pharmaceuticals) Eli Lilly and Company Health Insurance and Managed Care Novo Nordisk A/S Obesity Ozempic (Drug) Prices (Fares, Fees and Rates) Semaglutide (Drug) Tirzepatide

How Much Do Ozempic and Wegovy Cost? Not What You Think.

Drug companies are making billions from a new class of in-demand weight-loss treatments. But the prices are not what they seem.

By Gina Kolata